Телектол®

General characteristics. Structure:

Active ingredient: 5 mg or 10 mg of a Vinpocetine in 1 tablet.

 Excipients: (starch prezhelatinizirovanny, lactose, кополивидон, cellulose mikrokrisallichesky, magnesium stearate, talc, silicon dioxide colloid (aerosil), gipromelloz, macrogoal, titanium dioxide, dye blue).

The drug improving blood circulation and metabolism of a brain. Has vasodilating, anti-hypoxemic and antiagregantny effect.

Pharmacological properties:

Pharmacodynamics. Possesses vasodilating, anti-hypoxemic and anti-aggregation action. Inhibits a fosfodiestiraa and increases the content of cyclic adenosinemonophosphate in cells that, in turn, leads to decrease in content of calcium in cytoplasm of smooth muscle cells and to relaxation of myofibrils.

Combines vascular and metabolic actions. Expands brain vessels, strengthens a blood stream. Preferential in ischemic areas, improves supply of a brain with oxygen. Promotes utilization of glucose and increases the level of catecholamines in the central nervous system, stimulates metabolism of noradrenaline and serotonin in brain tissues. Reduces aggregation of thrombocytes, viscosity of blood, promotes increase in deformability of erythrocytes and normalization of venous outflow against the background of decrease in resistance of brain vessels. System arterial pressure slightly goes down.

It is effective in the acute period of a stroke: accelerates regress of all-brain and focal neurologic symptomatology, improves memory, attention, intellectual productivity. Sensitivity of brain vessels to the running-down action of a Vinpocetine increases in advanced and senile age that is caused by a sensitization of system of adenylatecyclase – cyclic adenosinemonophosphate when aging.

Pharmacokinetics. It is quickly soaked up from digestive tract. Bioavailability about 60%. The maximum concentration in a blood plasma is reached in 1 hour. Easily diffuses through gistogematichesky barriers (including through a blood-brain barrier) and gets into fabrics. Elimination half-life about 5 hours.

Indications to use:

Acute (after the termination of a course of parenteral administration of a Vinpocetine, and also in cases when the parentalnoyevvedeniye is not shown or it is impossible) and chronic forms of insufficiency of cerebral circulation (including acute and residual stages of a stroke, the tranzitorny ischemic attacks, encephalopathies, multiinfarctive dementia).

Vascular diseases of a retina and/or choroid of an eye owing to arteriosclerosis, a vasomotor spasm, thrombosis); the degenerative changes of a macula lutea caused by atherosclerosis or a vasomotor spasm; secondary glaucoma (owing to obturation of vessels).

Age vascular or toxic (medicamentous) hearing disorder, Menyer's disease, dizzinesses of a labyrinth origin. Vegetative manifestations of a menopausal syndrome.

Route of administration and doses:

Inside on 5-10 mg 3 times a day within 2 months. Before drug withdrawal it is necessary to reduce a dosage gradually. Repeated courses 2-3 times a year are possible.

At diseases of kidneys or a liver drug is appointed in a usual dose.

Side effects:

Lowering of arterial pressure, tachycardia, premature ventricular contraction, delay of intra ventricular conductivity.

Interaction with other medicines:

Increases risk of hemorrhagic complications against the background of a geparinoterapiya.

Contraindications:

Hypersensitivity, the expressed disturbances of a heart rhythm, coronary heart disease (heavy current), acute stage of a hemorrhagic stroke, beremnnost, the lactation period.

Overdose:

At intoxication the gastric lavage, reception of absorbent carbon and symptomatic treatments are recommended.

Storage conditions:

List B. In dry, protected from light and the place, unavailable to children, at a temperature not above 25 °C. A period of validity - 2 years. Not to use after the period of validity specified on packaging.

Issue conditions:

According to the recipe

Packaging:

Tablets, coated, 5 mg and 10 mg. On 10, 15, 20, 30 tablets in a blister strip packaging. 1, 2, 3, 5 or 10 blister strip packagings together with the application instruction place in a pack from a cardboard.